Imaging & Diagnostics

Can 18F-FAPI PET/CT Improve Papillary Thyroid Cancer Staging?
Imaging & Diagnostics Can 18F-FAPI PET/CT Improve Papillary Thyroid Cancer Staging?

Surgeons often struggle with the decision of how aggressive a neck dissection should be when preoperative ultrasound provides ambiguous information about nodal involvement. This dilemma is particularly acute in the management of differentiated thyroid cancer, where papillary thyroid carcinoma (PTC)

Can Data-Driven Gating Improve PSMA PET/CT Image Quality?
Imaging & Diagnostics Can Data-Driven Gating Improve PSMA PET/CT Image Quality?

While 6Ga-PSMA and 18F-DCFPyL are cornerstones of modern prostate cancer diagnostics, their effectiveness is limited by the respiratory 'blur' that occurs in the chest and abdomen. This phenomenon is a persistent technical obstacle in nuclear medicine because Positron Emission Tomography/Computed

Can PSMA-PET/CT Help Men Avoid Invasive Prostate Biopsies?
Imaging & Diagnostics Can PSMA-PET/CT Help Men Avoid Invasive Prostate Biopsies?

Medical researchers at the University of Vienna are investigating whether dual-modality imaging can accurately identify which patients with elevated PSA levels truly require a biopsy. For decades, the standard protocol for suspected prostate cancer has relied heavily on the Prostate-Specific

Can a Heart Mass Be Metastatic Primary Urethral Cancer?
Imaging & Diagnostics Can a Heart Mass Be Metastatic Primary Urethral Cancer?

Severe exertional dyspnea and intestinal obstruction marked the final stages of the patient's seventeen-month battle with this rare and invasive form of urethral malignancy. Primary urethral carcinoma remains one of the most elusive and devastating urological conditions, accounting for less than

Can PET/CT Measures Predict Early Breast Cancer Recurrence?
Imaging & Diagnostics Can PET/CT Measures Predict Early Breast Cancer Recurrence?

The transition from intensity-based to volume-based metabolic assessment represents a significant shift in how oncologists might predict early treatment failure. While traditional staging systems rely heavily on tumor size and lymph node status, they often overlook the metabolic intricacies that

How Will AI Integration Transform Krsnaa Diagnostics?
Imaging & Diagnostics How Will AI Integration Transform Krsnaa Diagnostics?

Integrating AI technology into the existing teleradiology workflow allows Krsnaa to maximize the utilization of its capital assets without increasing fixed costs. This strategic partnership with Azmed reflects a broader movement within the healthcare sector to stabilize diagnostic accuracy while

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later